Lucknow: Antimicrobial resistance (AMR) has emerged as one of the most serious public health challenges in India, compromising the treatment of common.

Pune: Despite the global threat of antimicrobial resistance (AMR), official data from PMC indicates a decline in multi-drug resistant tuberculosis (MDR-TB), with cases falling from 326 in 2024 to 267 ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

An extensive sample of patients revealed new drug-resistant strains of tuberculosis particularly in Eastern Europe. These strains could spread to the EU. The evolution and contagion methods of the ...

Drug-resistant tuberculosis remains one of the most persistent infectious disease threats, driven in large part by ...

Delhi’s Intermediate Reference Laboratory (IRL) at the New Delhi Tuberculosis Centre has received certification from the Central Tuberculosis Division (CTD), Government of India, to conduct drug ...

NEW DELHI -More than 80 per cent of Indian patients carry multidrug-resistant organisms (MDROs), the highest globally, according to an alarming study released on November 18. This reflects the deep ...

Mumbai's tuberculosis programme has reported an encouraging milestone: 89 patients, from the over 1,000 with drug-resistant TB (DR-TB) placed on a new six-month treatment regimen, have been declared ...

Though tuberculosis is rare in the United States as compared to developing countries, the San Francisco Bay Area has some of the highest rates in the state.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.